ARWR
NASDAQ · Biotechnology
Arrowhead Pharmaceuticals In
$72.69
-5.26 (-6.75%)
Performance
1D
—
1W
—
1M
—
3M
+16.04%
6M
+75.16%
1Y
+420.33%
YTD
+7.23%
Open$76.50
Previous Close$77.95
Day High$77.92
Day Low$72.61
52W High$79.48
52W Low$12.44
Volume—
Avg Volume1.52M
Market Cap10.30B
P/E Ratio50.91
EPS$1.54
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$66.84
Above
SMA 200
$36.65
Above
RSI (14)
36.5
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
19 analysts
Price Target
-4.4% upside
Current
$72.69
$72.69
Target
$69.50
$69.50
$62.98
$69.50 avg
$88.85
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 878.51M | 583.65M | 3.64B |
| Net Income | -1,728,369 | -1,033,438 | -138,687,526 |
| Profit Margin | -0.2% | -0.2% | -3.8% |
| EBITDA | 135.08M | 85.26M | -183,881,108 |
| Free Cash Flow | — | — | -98,110,953 |
| Rev Growth | +50.5% | +50.5% | +9.5% |
| Debt/Equity | 1.34 | 1.34 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |